MAR002 is an early, promising development: a new take on a proven strategy, with the potential for stronger IGF-1 control and dramatically less frequent dosing. At the same time, it’s important to keep expectations grounded. The drug is still investigational. It is not approved, not yet available outside clinical trials, and a larger patient study is needed to confirm what the early data suggest.
From the desk of J D Faccinetti Chairman, CEO and chief editor Pituitary World News. We recently published two COVID-19 related articles that focused on subjects that are very much in everyone’s mind. One was
At the risk of adding to the Coronavirus news frenzy we’re experiencing, I thought this piece from Gil Bashe, a health communication writer, deserved to be noted. His article points to the substandard job the health
A commentary from Dr. Lewis S Blevins Jr. co-founder – I was recently asked if I felt that we would ever be able to use stem cells to regenerate the pituitary gland. Frankly, the answer is
From Lewis S. Blevins Jr. M.D. – This interesting manuscript – BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY – reports the outcomes data of management of
We continue to periodically publish videos of pituitary MRI’s with discussions on the images in an effort to make people more familiar with these studies, help in the understanding of these images, what you see, and
From the desk of Lewis S Blevins Jr M.D. co-founder – As telemedicine expands, more and more health centers are providing this service to patients. In fact, during the week that we recorded this podcast,
Recently we told you about Chiasma’s latest news in both Phase 3 clinical trials of oral octreotide capsules product candidates, which are well on the way. You can read more about the company and the
From the Desk of JD Faccinetti – cofounder. Today in our spotlight section we take a look at The Pituitary Society, one of the leading scientific organization dedicated to the understanding of diseases of the
Dr. Sandeep Kunwar is by all counts one of the most, if not the most, successful pituitary surgeon today. In this fascinating podcast, we talked about pituitary surgery, his views, interests, passions, and the future. Here are some the
From J D Faccinetti – cofounder – I met Santino Matrundola about a year ago in Vancouver at the Canadian Acromegaly gathering of physicians and patients. We were both asked to present, he his story
A commentary by J D Faccinetti cofounder– In this day and age of hyper communications, internet speed, ultra-connected populations, and copious amounts of easily accessible content, bad information is rampant. That’s a problem. A big